# Moxifloxacin

## Vigamox 0.5%， 5mL ophthalmic solution

| TAH Drug Code      | [EVIG](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EVIG)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | The treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram-positive microorganisms (Corynebacterium species， Micrococcus luteus， Staphylococcus aureus， Staphylococcus epidermidis， Staphylococcus haemolyticus， Staphylococcus hominis， Staphylococcus warneri， Streptococcus pneumoniae， Streptococcus viridans group)， Aerobic Gram-negative microorganisms (Acinetobacter lwoffii， Haemophilus influenzae， Haemophilus parainfluenzae)， Other microorganisms (Chlamydia trachomatis). |
| Dosing             | instill 1 drop in the affected eye TID for 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | History of hypersensitivity to moxifloxacin， to other quinolones， or to any of the components in this medication.                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Conjunctivitis， decreased visual acuity， dry eye， keratitis， ocular discomfort， ocular hyperemia， ocular pain， ocular pruritus， subconjunctival hemorrhage， and tearing.(1-6%) Fever， increased cough， infection， otitis media， pharyngitis， rash， and rhinitis.(1-4%)                                                                                                                                                                                                                                                                       |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/moxifloxacin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

